Apyx Medical (APYX) Operating Leases (2019 - 2026)

Apyx Medical's Operating Leases history runs 8 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• Quarterly Operating Leases fell 10.51% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 10.51% YoY) and the FY2025 annual result came in at $4.1 million, down 9.64% from the prior year.
• Operating Leases was $3.9 million for Q1 2026 at Apyx Medical, down from $4.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.4 million in Q2 2023 and bottomed at $448000.0 in Q1 2023.
• A 5-year average of $3.6 million and a median of $4.3 million in 2025 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases surged 2213.33% — and 2024, when it slipped 13.5%.
• Apyx Medical's Operating Leases stood at $470000.0 in 2022, then surged by 941.7% to $4.9 million in 2023, then decreased by 8.44% to $4.5 million in 2024, then declined by 9.64% to $4.1 million in 2025, then fell by 3.09% to $3.9 million in 2026.
• Business Quant data shows APYX's Operating Leases at $3.9 million in Q1 2026, $4.1 million in Q4 2025, and $4.2 million in Q3 2025.